140 related articles for article (PubMed ID: 35598422)
1. New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity.
Lima S; Banerjee A; Sahu G; Patra SA; Sahu K; Sasamori T; Sciortino G; Garribba E; Dinda R
J Inorg Biochem; 2022 Aug; 233():111853. PubMed ID: 35598422
[TBL] [Abstract][Full Text] [Related]
2. Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity.
Sahu G; Patra SA; Mohanty M; Lima S; Pattanayak PD; Kaminsky W; Dinda R
J Inorg Biochem; 2022 Aug; 233():111844. PubMed ID: 35512606
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction.
Banerjee A; Dash SP; Mohanty M; Sanna D; Sciortino G; Ugone V; Garribba E; Reuter H; Kaminsky W; Dinda R
J Inorg Biochem; 2019 Oct; 199():110786. PubMed ID: 31377474
[TBL] [Abstract][Full Text] [Related]
4. A Series of Non-Oxido V
Banerjee A; Patra SA; Sahu G; Sciortino G; Pisanu F; Garribba E; Carvalho MFNN; Correia I; Pessoa JC; Reuter H; Dinda R
Inorg Chem; 2023 May; 62(20):7932-7953. PubMed ID: 37154533
[TBL] [Abstract][Full Text] [Related]
5. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex.
Patra SA; Mohanty M; Banerjee A; Kesarwani S; Henkel F; Reuter H; Dinda R
J Inorg Biochem; 2021 Nov; 224():111582. PubMed ID: 34450411
[TBL] [Abstract][Full Text] [Related]
6. Versatile Reactivity and Theoretical Evaluation of Mono- and Dinuclear Oxidovanadium(V) Compounds of Aroylazines: Electrogeneration of Mixed-Valence Divanadium(IV,V) Complexes.
Dash SP; Roy S; Mohanty M; Carvalho MF; Kuznetsov ML; Pessoa JC; Kumar A; Patil YP; Crochet A; Dinda R
Inorg Chem; 2016 Sep; 55(17):8407-21. PubMed ID: 27551768
[TBL] [Abstract][Full Text] [Related]
7. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
8. Water-Soluble Dioxidovanadium(V) Complexes of Aroylhydrazones: DNA/BSA Interactions, Hydrophobicity, and Cell-Selective Anticancer Potential.
Sahu G; Banerjee A; Samanta R; Mohanty M; Lima S; Tiekink ERT; Dinda R
Inorg Chem; 2021 Oct; 60(20):15291-15309. PubMed ID: 34597028
[TBL] [Abstract][Full Text] [Related]
9. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA/BSA interaction and in vitro cell cytotoxicity of μ
Patra SA; Banerjee A; Sahu G; Mohanty M; Lima S; Mohapatra D; Görls H; Plass W; Dinda R
J Inorg Biochem; 2022 Aug; 233():111852. PubMed ID: 35580515
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
[TBL] [Abstract][Full Text] [Related]
12. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
13. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
14. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
[TBL] [Abstract][Full Text] [Related]
15. Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes.
Biswal D; Pramanik NR; Chakrabarti S; Drew MGB; Acharya K; Chandra S
Dalton Trans; 2017 Dec; 46(47):16682-16702. PubMed ID: 29168865
[TBL] [Abstract][Full Text] [Related]
16. ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.
Ugone V; Sanna D; Sciortino G; Crans DC; Garribba E
Inorg Chem; 2020 Jul; 59(14):9739-9755. PubMed ID: 32585093
[TBL] [Abstract][Full Text] [Related]
17. New mononuclear and binuclear oxomolybdenum(V) complexes containing NN chelator: Syntheses, DFT calculations, interaction with BSA protein and in vitro cytotoxic activity.
Roy M; Biswal D; Sarkar O; Pramanik NR; Drew MGB; Sadhukhan P; Kundu M; Sil PC; Chakrabarti S
J Inorg Biochem; 2019 Oct; 199():110755. PubMed ID: 31299376
[TBL] [Abstract][Full Text] [Related]
18. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
19. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
[TBL] [Abstract][Full Text] [Related]
20. Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.
Yuan C; Lu L; Gao X; Wu Y; Guo M; Li Y; Fu X; Zhu M
J Biol Inorg Chem; 2009 Aug; 14(6):841-51. PubMed ID: 19290551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
